{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:44Z","timestamp":1793235104511,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioadv.2025.214586","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:00Z","timestamp":1761870660000},"page":"214586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Formulation and evaluation of hydrogel-forming microarray patches for transdermal primaquine and chloroquine delivery in malaria therapy"],"prefix":"10.1016","volume":"180","author":[{"given":"Qonita Kurnia","family":"Anjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Volpe-Zanutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andang","family":"Miatmoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Adhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaina Tenorio","family":"Novais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara A.","family":"Gait\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berlian Sarasitha","family":"Hariawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy Maulidya","family":"Cahyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifda Tarimi","family":"Octavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Shahrul","family":"Mubarok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwit Ananda Wahyu","family":"Setyaningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Bargieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214586_bb0005","unstructured":"World malaria report 2024, (n.d.). https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024 (accessed September 23, 2025)."},{"key":"10.1016\/j.bioadv.2025.214586_bb0010","article-title":"Genetic characterization of plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study","volume":"48","author":"Barratt","year":"2025","journal-title":"Lancet Region. Health Am."},{"key":"10.1016\/j.bioadv.2025.214586_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003799","article-title":"The global burden of Plasmodium vivax malaria is obscure and insidious","volume":"18","author":"Battle","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.bioadv.2025.214586_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.omtm.2022.07.016","article-title":"Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine","volume":"26","author":"Flannery","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bioadv.2025.214586_bb0025","article-title":"Primaquine for preventing relapse in people with plasmodium vivax malaria treated with chloroquine","volume":"2013","author":"Galappaththy","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioadv.2025.214586_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-022-00408-5","article-title":"Is it time for Africa to adopt primaquine in the era of malaria control and elimination?","volume":"50","author":"Mwaiswelo","year":"2022","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.bioadv.2025.214586_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2015.10.008","article-title":"The antimalarial drug primaquine targets Fe\u2013S cluster proteins and yeast respiratory growth","volume":"7","author":"Lal\u00e8ve","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioadv.2025.214586_bb0040","doi-asserted-by":"crossref","first-page":"e0006230","DOI":"10.1371\/journal.pntd.0006230","article-title":"Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries","volume":"12","author":"Recht","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioadv.2025.214586_bb0045","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/654815","article-title":"On the cytoadhesion of plasmodium vivax-infected erythrocytes","volume":"202","author":"Carvalho","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioadv.2025.214586_bb0050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1286-4579(03)00162-X","article-title":"Cytoadherence and sequestration in plasmodium falciparum: defining the ties that bind","volume":"5","author":"Sherman","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bioadv.2025.214586_bb0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","article-title":"Hemozoin biocrystallization in plasmodium falciparum and the antimalarial activity of crystallization inhibitors","volume":"100","author":"Hempelmann","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bioadv.2025.214586_bb0060","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1038\/s41598-021-86079-4","article-title":"The toxic effects of chloroquine and hydroxychloroquine on skeletal muscle: a systematic review and meta-analysis","volume":"11","author":"Biguetti","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214586_bb0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12012-020-09621-2","article-title":"QTc prolongation in COVID-19 patients using chloroquine","volume":"21","author":"Becker","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.bioadv.2025.214586_bb0070","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/cid\/ciy236","article-title":"Expanding the use of Primaquine for the radical cure of plasmodium vivax","volume":"67","author":"Price","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioadv.2025.214586_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2023.05.063","article-title":"Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in children","volume":"134","author":"Moore","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bioadv.2025.214586_bb0080","series-title":"BNF 82 (British National Formulary) September 2021","author":"Committee","year":"2021"},{"key":"10.1016\/j.bioadv.2025.214586_bb0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14787210.2016.1220304","article-title":"Management of relapsing plasmodium vivax malaria","volume":"14","author":"Chu","year":"2016","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.bioadv.2025.214586_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04725-w","article-title":"Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis","volume":"22","author":"Mehdipour","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.bioadv.2025.214586_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-024-05124-5","article-title":"In vivo efficacy of chloroquine plus primaquine combination therapy against uncomplicated plasmodium vivax malaria in Limu Kossa District, Jimma Zone, Southwest Ethiopia","volume":"23","author":"Asfaw","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.bioadv.2025.214586_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2023.05.038","article-title":"Microarray patches for managing infections at a global scale","volume":"359","author":"Anjani","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214586_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0111547","article-title":"Hydrogel-forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery","volume":"9","author":"Donnelly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2025.214586_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jconrel.2023.08.009","article-title":"Primaquine and chloroquine nano-sized solid dispersion-loaded dissolving microarray patches for the improved treatment of malaria caused by Plasmodium vivax","volume":"361","author":"Anjani","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214586_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejpb.2020.12.003","article-title":"Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs","volume":"294\u2013312","author":"Anjani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125061","article-title":"Hydrogel-forming microarray patches combined with powder-based reservoir for labetalol hydrochloride transdermal delivery","volume":"669","author":"Anjani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0125","article-title":"Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin","volume":"617","author":"Bin Sabri","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0130","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1039\/D4TB00110A","article-title":"Novel SmartReservoirs for hydrogel-forming microneedles to improve the transdermal delivery of rifampicin","volume":"12","author":"Abraham","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2025.214586_bb0135","article-title":"Synthesis and characterization of sorbitol laced hydrogel-forming microneedles for therapeutic drug monitoring","volume":"607","author":"Bin Sabri","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40005-024-00682-x","article-title":"Formulation and evaluation of ivermectin-loaded dissolving microarray patches for rosacea disease","volume":"54","author":"Anjani","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.bioadv.2025.214586_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114304","article-title":"Dissolvable microarray patches of levodopa and carbidopa for Parkinson\u2019s disease management","volume":"199","author":"Anjani","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-022-02422-6","article-title":"In vitro permeation studies on carvedilol containing dissolving microarray patches quantified using a rapid and simple HPLC-UV analytical method","volume":"23","author":"Anjani","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214586_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121194","article-title":"Tip loaded cyclodextrin-carvedilol complexes microarray patches","volume":"320","author":"Anjani","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2025.214586_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124071","article-title":"Parafilm\u00ae M and Strat-M\u00ae as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins","volume":"655","author":"Anjani","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larraneta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0170","unstructured":"Dosing Recommendations for Prevention and Treatment of Malaria | NIH, (n.d.). https:\/\/clinicalinfo.hiv.gov\/en\/table\/dosing-recommendations-prevention-and-treatment-malaria (accessed September 23, 2025)."},{"key":"10.1016\/j.bioadv.2025.214586_bb0175","first-page":"385","article-title":"Primaquine and chloroquine nano-sized solid dispersion-loaded dissolving microarray patches for the improved treatment of malaria caused by Plasmodium vivax","volume":"361","author":"Kurnia","year":"2023"},{"key":"10.1016\/j.bioadv.2025.214586_bb0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/11535340-000000000-00000","article-title":"Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work","volume":"33","author":"Suzuki","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioadv.2025.214586_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00572-x","article-title":"A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission","volume":"8","author":"Baker","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2025.214586_bb0190","first-page":"298","article-title":"Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii","volume":"333","author":"Volpe-Zanutto","year":"2021"},{"key":"10.1016\/j.bioadv.2025.214586_bb0195","series-title":"EMA\/CHMP\/ICH\/172948\/2019 - ICH Guideline M10 on Bioanalytical Method Validation, EMA Guidance Document","first-page":"57","volume":"44","author":"European Medicines Agency","year":"2019"},{"key":"10.1016\/j.bioadv.2025.214586_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123081","article-title":"A five-day treatment course of zanamivir for the flu with a single, self-administered, painless microneedle array patch: revolutionizing delivery of poorly membrane-permeable therapeutics","volume":"641","author":"Reyna","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.1997.tb52194.x","article-title":"Factors determining hydrogel permeability","volume":"831","author":"Gehrke","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioadv.2025.214586_bb0210","series-title":"Biomedical applications of hydrogels handbook","author":"Ottenbrite","year":"2010"},{"key":"10.1016\/j.bioadv.2025.214586_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-021-01939-6","article-title":"Emerging multi-drug eutectics: opportunities and challenges","volume":"22","author":"Haneef","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214586_bb0220","article-title":"Novel co-crystals and eutectics of Febuxostat: characterization, mechanism of formation, and improved dissolution","volume":"23","author":"Jagia","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214586_bb0225","first-page":"1","article-title":"Quercetin loaded polymeric dissolving microarray patches: fabrication, characterisation and evaluation","author":"Anjani","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2025.214586_bb0230","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2023.03.003","article-title":"Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug","volume":"356","author":"Naser","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214586_bb0235","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/acs.molpharmaceut.1c00988","article-title":"Elucidating the impact of surfactants on the performance of dissolving microneedle array patches","volume":"19","author":"Anjani","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123446","article-title":"Liposome-loaded polymeric microneedles for enhanced skin deposition of rifampicin","volume":"646","author":"Anjani","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214586_bb0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pt.2022.05.003","article-title":"Pharmacokinetic considerations in seasonal malaria chemoprevention","volume":"38","author":"Chotsiri","year":"2022","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioadv.2025.214586_bb0250","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioadv.2025.214586_bb0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jconrel.2022.06.028","article-title":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV pre-exposure prophylaxis","volume":"348","author":"Volpe-Zanutto","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214586_bb0260","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946201860066","article-title":"Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin","volume":"60","author":"Mello","year":"2018","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.bioadv.2025.214586_bb0265","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.1983.tb02244.x","article-title":"Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria","volume":"16","author":"Walker","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214586_bb0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2020.1817479","article-title":"Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose","volume":"59","author":"Doyno","year":"2021","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.bioadv.2025.214586_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100463","article-title":"Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers","volume":"45","author":"Khan","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bioadv.2025.214586_bb0280","series-title":"StatPearls [Internet]","article-title":"Chloroquine and Hydroxychloroquine Toxicity","author":"Stokkermans","year":"2025"},{"key":"10.1016\/j.bioadv.2025.214586_bb0285","series-title":"Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis","year":"2020"},{"key":"10.1016\/j.bioadv.2025.214586_bb0290","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","article-title":"The effect of chloroquine dose and primaquine on plasmodium vivax recurrence: a WorldWide antimalarial resistance network systematic review and individual patient pooled meta-analysis","volume":"18","author":"Commons","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioadv.2025.214586_bb0295","first-page":"1","article-title":"Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes","volume":"1 11","author":"Miatmoko","year":"2021","journal-title":"Sci. Rep. 2021 11"},{"key":"10.1016\/j.bioadv.2025.214586_bb0300","unstructured":"Safety Data Sheet acc. to OSHA HCS, n.d. https:\/\/cdn.caymanchem.com\/cdn\/msds\/14194m.pdf (accessed June 24, 2025)."},{"key":"10.1016\/j.bioadv.2025.214586_bb0305","unstructured":"Safety Data Sheet acc. to OSHA HCS, n.d. https:\/\/cdn.caymanchem.com\/cdn\/msds\/18223m.pdf?utm_source=chatgpt.com (accessed June 24, 2025)."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825004133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825004133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:03:00Z","timestamp":1765213380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825004133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":61,"alternative-id":["S2772950825004133"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214586","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and evaluation of hydrogel-forming microarray patches for transdermal primaquine and chloroquine delivery in malaria therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214586"}}